在乳腺癌骨,肝脏和肺部转移中的雌激素受体转化
Peter Podany1, Haiying Zhan1, Di Ai2
1Department of Pathology, Yale School of Medicine, New Haven, CT 06520, United States.
Pathology, research and practice
|September 18, 2025
概括
乳腺癌中的生物标志物状态可以从原发性瘤转变为转移,特别是在肝脏. 这种雌激素受体 (ER) 转换与更差的生存率和特定的遗传突变有关.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 乳腺癌的治疗依赖于生物标志物状态,这种状态可以在原发性瘤和转移之间发生变化.
- 了解生物标志物转化对于调整患者管理策略至关重要.
研究的目的:
- 研究乳腺生物标志物 (特别是雌激素受体 - ER) 在骨,肝脏和肺转移中的转化.
- 为了将生物标志物转换与临床病理学因素,预后和遗传变化相关联.
主要方法:
- 分析初级瘤中的生物标志物状况及其相应的骨,肝脏和肺转移.
- 在不同转移性部位的生物标志物转化率的比较.
- ER转换与患者存活率和TP53/PIK3CA突变的相关性.
主要成果:
- 肝转移表明,与骨 (5.7%) 和肺 (7.7%) 相比,ER转化率更高 (35%).
- 15%的总人口 (10/68例) 呈现ER转换,7例从阳性转化为阴性,3例从阴性转化为阳性 (全部在肝脏中).
- ER转化与中位生存时间 (12个月与38个月) 的缩短显著相关,并与TP53和PIK3CA突变相关.
结论:
- 肝脏是一个转移性部位,具有更高的ER转化倾向.
- 无论方向如何,ER转换是乳腺癌的负预后指标.
- ER转换可能受到TP53和PIK3CA等特定基因突变的影响.
相关概念视频
Transducer Mechanism: Nuclear Receptors
2.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.4K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K


